Skip to content

155 SCE Hemodialyzer

by Althin Medical AB an Affiliate of Baxter Intl

510(k) K945631

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK945631 Date18 May 1995ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
155 Sce(Tm) Hemodialyzer
510(k) Number
FDA Product Code
FJI
Device Class
Class II
Regulation
21 CFR Part 876.5820
Advisory Committee
Gastroenterology, Urology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The 155 SCE Hemodialyzer is a dialyzer, capillary, hollow fiber designed for hemodialysis. It functions as an artificial kidney to remove waste products, excess fluids, and electrolytes from the blood of patients with renal failure by diffusion and ultrafiltration through semipermeable hollow fiber membranes.

This device is supplied sterile and intended for single-use in clinical settings. It is classified under FDA product code FJI and regulated under 21 CFR 876.5820, with a 510(k) clearance (K945631) granted in 1995. Standard sizes and configurations are available as specified in the original submission, adhering to FDA’s Substantially Equivalent (SESE) determination for Class II devices.

Other devices from Althin Medical AB an Affiliate of Baxter Intl

See all devices from Althin Medical AB an Affiliate of Baxter Intl →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the 155 SCE Hemodialyzer used for?

    The 155 SCE Hemodialyzer is designed as an artificial kidney to perform hemodialysis. It removes waste products, excess fluids, and electrolytes from the blood of patients with renal failure through diffusion and ultrafiltration. The semipermeable hollow fiber membranes facilitate these processes, mimicking the function of healthy kidneys.

  • Is the 155 SCE Hemodialyzer sterile and single-use?

    Yes, the 155 SCE Hemodialyzer is supplied sterile and intended for single-use in clinical settings. This ensures patient safety by preventing cross-contamination and maintaining device integrity for one treatment cycle only.

  • What are the key specifications or configurations available for this device?

    The 155 SCE Hemodialyzer is available in standard sizes and configurations as originally submitted to the FDA. These details are documented in the device’s submission records, adhering to FDA’s Substantially Equivalent (SESE) determination for Class II devices. Specific dimensions or variations are not listed in the provided data, but the device is designed for compatibility with standard hemodialysis systems.

  • How should the 155 SCE Hemodialyzer be stored?

    While the provided data does not specify storage instructions, sterile medical devices like the 155 SCE Hemodialyzer are typically stored in a clean, dry environment, protected from direct sunlight, extreme temperatures, and physical damage. Always follow the manufacturer’s instructions or accompanying documentation for optimal storage conditions to preserve sterility and functionality.

  • What regulatory pathway does the 155 SCE Hemodialyzer follow?

    The 155 SCE Hemodialyzer was granted a 510(k) clearance (K945631) by the FDA in 1995 under the Traditional clearance type. It is classified under FDA product code FJI and regulated under 21 CFR 876.5820. The device was determined to be Substantially Equivalent (SESE) to a legally marketed predicate, ensuring compliance with FDA standards for Class II medical devices.